Prosecution Insights
Last updated: April 19, 2026

Bicycletx Limited

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18313983 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EphA2 KATAKAM, SUDHAKAR 1658 Non-Final OA May 08, 2023
18021748 BICYCLE CONJUGATES SPECIFIC FOR NECTIN-4 AND USES THEREOF MYERS, CARLA J 1682 Non-Final OA Feb 16, 2023
18001374 TREATMENT OF DISEASES CHARACTERIZED BY OVEREXPRESSION OF ERYTHROPOIETIN-PRODUCING HEPATOCELLULAR RECEPTOR A2 (EPHA2) PUTTLITZ, KARL J 1646 Non-Final OA Dec 09, 2022
17926454 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 AND USES THEREOF BELYAVSKYI, MICHAIL A 1644 Final Rejection Nov 18, 2022
17630747 HETEROTANDEM BICYCLIC PEPTIDE COMPLEXES DABKOWSKI, ERINNE R 1654 Non-Final OA Jan 27, 2022
17309626 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP D' AMBROSIO, THEA 1654 Final Rejection Jun 11, 2021

Managing Bicycletx Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month